MDGL Target Price: 88% Confidence
MDGL has been forming a bullish Head-and-Shoulders Bottom pattern since February 28, 2023. This pattern is a reliable bullish indicator and occurs when a stock's price falls to a low, bounces back up, forms a lower low, bounces back up again to form a higher low, and then breaks above the resistance level formed by the neckline of the pattern. This pattern signals that the stock is likely to experience a bullish move in the near future.
The Head-and-Shoulders Bottom pattern for MDGL was confirmed on April 24, 2023, when the stock broke above the neckline of the pattern. This confirmed the bullish signal and suggested that the stock could be headed higher in the coming weeks.
Currently, there is a high confidence level of 88% that MDGL will reach the target price of 358.47 USD. The distance to the target price is 17%, which means that there is still some room for the stock to move higher. The breakout (entry) price is 306.92 USD, which can be used as a reference point for traders to enter the stock.
Adding to the bullish sentiment is the recent trigger of the Aroon Indicator. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. This is a sign that the stock is setting up for a bullish move. In fact, A.I.dvisor looked at 147 similar instances where the Aroon Indicator showed a similar pattern, and in 127 of those cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 86%.
In conclusion, MDGL's Head-and-Shoulders Bottom pattern and the recent trigger of the Aroon Indicator suggest that the stock is likely to experience a bullish move in the coming weeks. With a high confidence level of 88% and the distance to the target price at 17%, there is still room for the stock to move higher. Traders may want to consider buying the stock or look to buy call options to take advantage of the potential upside.
Contributor
MDGL in -4.16% downward trend, falling for three consecutive days on October 13, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MDGL declined for three days, in 260 of 328 cases, the price declined further within the following month. The odds of a continued downward trend are 79%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MDGL as a result. In 69 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for MDGL turned negative on September 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 29 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
MDGL moved below its 50-day moving average on September 21, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MDGL crossed bearishly below the 50-day moving average on September 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.
The Aroon Indicator for MDGL entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +0.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where MDGL advanced for three days, in 222 of 291 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
MDGL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 21 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. MDGL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (22.831) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (9.443) is also within normal values, averaging (437.542).
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases
Industry Biotechnology
Advertisement